-
16615-50A cell-permeable inhibitor of PTPs (IC<sub>50</sub>s = 0.09-1.
-
12050-1BW 245C is a selective agonist for the DP1 receptor. The Ki of BW 245C for the inhibition of [3H]-PGD2 binding to isolated human platelet membranes is 0.
-
12050-10BW 245C is a selective agonist for the DP1 receptor. The Ki of BW 245C for the inhibition of [3H]-PGD2 binding to isolated human platelet membranes is 0.
-
12050-5BW 245C is a selective agonist for the DP1 receptor. The Ki of BW 245C for the inhibition of [3H]-PGD2 binding to isolated human platelet membranes is 0.
-
12055-1BW 246C is the less active C-8 diastereomer of the DP1 receptor agonist BW 245C. The activity of BW 245C is 70-fold greater than that of BW 246C.
-
12055-10BW 246C is the less active C-8 diastereomer of the DP1 receptor agonist BW 245C. The activity of BW 245C is 70-fold greater than that of BW 246C.
-
12055-5BW 246C is the less active C-8 diastereomer of the DP1 receptor agonist BW 245C. The activity of BW 245C is 70-fold greater than that of BW 246C.
-
70090-1An anxiolytic compound that causes hyperphagia, which likely due to its 10-fold selectivity for the 5-HT2B receptor direct infusion of 1-3 µg into the cerebral ventricles of rats evokes maximal behavioral responses.
-
70090-10An anxiolytic compound that causes hyperphagia, which likely due to its 10-fold selectivity for the 5-HT2B receptor direct infusion of 1-3 µg into the cerebral ventricles of rats evokes maximal behavioral responses.
-
70090-5An anxiolytic compound that causes hyperphagia, which likely due to its 10-fold selectivity for the 5-HT2B receptor direct infusion of 1-3 µg into the cerebral ventricles of rats evokes maximal behavioral responses.
-
70090-50An anxiolytic compound that causes hyperphagia, which likely due to its 10-fold selectivity for the 5-HT2B receptor direct infusion of 1-3 µg into the cerebral ventricles of rats evokes maximal behavioral responses.
-
15490-10A dual inhibitor of 5-LO and COX pathways, inhibiting 5-LO, COX-1, and COX-2 (IC<sub>50</sub>s = 0.75 &muM, 0.65 &mug/ml, and 1.2 &mug/ml, respectively) may also inhibit other LO pathways in vivo.